ARMATA PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
ARMATA PHARMACEUTICALS, INC. (ARMP) had Shares Outstanding (Cover Page) of 37.18 million shares as of 2026-08-06, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-06: Entity Common Stock, Shares Outstanding 37.18M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 36.71K shares.
- 2026-03-18: Entity Common Stock, Shares Outstanding 36.63M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 36.33M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 37.18M shares 10-Q · filed 2026-08-12 |
| 2026-05-08 | 36.71K shares 10-Q · filed 2026-05-13 |
| 2026-03-18 | 36.63M shares 10-K · filed 2026-03-25 |
| 2025-11-04 | 36.33M shares 10-Q · filed 2025-11-12 |
| 2025-08-06 | 36.23M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 36.19M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 36.18M shares 10-K · filed 2025-03-21 |
| 2024-11-08 | 36.18M shares 10-Q · filed 2024-11-13 |
| 2024-08-09 | 36.18M shares 10-Q · filed 2024-08-13 |
| 2024-04-30 | 36.15M shares 10-Q · filed 2024-05-07 |
| 2024-03-15 | 36.15M shares 10-K · filed 2024-03-21 |
| 2023-11-10 | 36.15M shares 10-Q · filed 2023-11-14 |
| 2023-08-04 | 36.13M shares 10-Q · filed 2023-08-14 |
| 2023-05-05 | 36.14M shares 10-Q · filed 2023-05-11 |
| 2023-03-13 | 36.14M shares 10-K · filed 2023-03-16 |
| 2022-11-04 | 36.14M shares 10-Q · filed 2022-11-09 |
| 2022-08-08 | 36.14M shares 10-Q · filed 2022-08-11 |
| 2022-05-06 | 36.11M shares 10-Q · filed 2022-05-12 |
| 2022-03-14 | 30.73M shares 10-K · filed 2022-03-17 |
| 2021-11-05 | 27.09M shares 10-Q · filed 2021-11-10 |
| 2021-08-09 | 24.94M shares 10-Q · filed 2021-08-12 |
| 2021-05-07 | 24.94M shares 10-Q · filed 2021-05-13 |
| 2021-03-17 | 24.94M shares 10-K · filed 2021-03-18 |
| 2020-11-05 | 18.70M shares 10-Q · filed 2020-11-12 |
| 2020-08-12 | 18.67M shares 10-Q · filed 2020-08-13 |
| 2020-05-06 | 18.64M shares 10-Q · filed 2020-05-14 |
| 2020-03-03 | 10.93M shares 10-K · filed 2020-03-19 |
| 2019-11-08 | 9.93M shares 10-Q · filed 2019-11-12 |
| 2019-08-09 | 9.96M shares 10-Q · filed 2019-08-14 |
| 2019-05-03 | 33.47M shares 10-Q · filed 2019-05-06 |
| 2019-03-08 | 32.29M shares 10-K · filed 2019-03-25 |
| 2018-11-05 | 32.29M shares 10-Q · filed 2018-11-08 |
| 2018-08-06 | 16.47M shares 10-Q · filed 2018-08-09 |
| 2018-05-10 | 16.46M shares 10-Q · filed 2018-05-15 |
| 2018-03-07 | 13.70M shares 10-K · filed 2018-03-14 |
| 2017-11-08 | 9.50M shares 10-Q · filed 2017-11-14 |
| 2017-08-09 | 8.75M shares 10-Q · filed 2017-08-14 |
| 2017-05-10 | 6.63M shares 10-Q · filed 2017-05-15 |
| 2017-03-17 | 16.49M shares 10-K · filed 2017-03-27 |
| 2016-11-10 | 11.12M shares 10-Q · filed 2016-11-10 |
| 2016-08-08 | 11.12M shares 10-Q · filed 2016-08-15 |
| 2016-05-06 | 8.24M shares 10-Q · filed 2016-05-12 |
| 2016-03-25 | 5.88M shares 10-K · filed 2016-03-30 |
| 2015-11-10 | 5.88M shares 10-Q · filed 2015-11-16 |
| 2015-08-13 | 5.78M shares 10-Q · filed 2015-08-13 |
| 2015-05-08 | 281.62M shares 10-Q · filed 2015-05-15 |
| 2015-04-10 | 277.95M shares 10-K · filed 2015-04-15 |
| 2014-10-20 | 187.16M shares 10-Q/A · filed 2015-04-15 |
| 2014-08-07 | 187.16M shares 10-Q/A · filed 2015-04-15 |
| 2014-05-05 | 182.54M shares 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |